| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |